Ticker ARMP – Armata Pharma – sales, description, marketcap – Tickerday.com

ARMP

Armata Pharma

–

Index: NYSE; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 55.63M; Volume: 0.00; AvgVol 3m: 15.76K; Beta: 2.19;

Cost estimate:

P/E: –; EPS: -1.95; EPS growth quarter/prev quarter: 54.10%;

EPS growth this year: 72.10%; EPS growth past 5 years: -14.90%;

EPS ttm: -1.95;

P/S: 1969.06; P/B: 02.02; P/Cashflow: 03.08; P/FCF: ;

Sales: 30.00K; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -57.50%; ROE – return on equity: -89.00%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.02;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 76.14%; Insider Transactions:0.00%;

Institutional Ownership: 11.40%; Institutional Transactions: 47.17%;

Data update: 07/10/2020.